share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dubin Michael F

SEC announcement ·  Jan 31 16:28
Summary by Moomoo AI
Michael F Dubin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], executed a transaction on January 29, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Michael F Dubin to the issuer was not specified, and there was no information provided regarding the number of shares held by Dubin after the transaction.
Michael F Dubin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], executed a transaction on January 29, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Michael F Dubin to the issuer was not specified, and there was no information provided regarding the number of shares held by Dubin after the transaction.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more